Norges Bank’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-129,506
| Closed | -$2.18M | – | 1310 |
|
|
2024
Q4 | $2.18M | Buy |
+129,506
| New | +$2.18M | ﹤0.01% | 1679 |
|
|
2021
Q1 | – | Sell |
-57,790
| Closed | -$2.02M | – | 2189 |
|
|
2020
Q4 | $2.02M | Buy |
+57,790
| New | +$2.02M | ﹤0.01% | 1953 |
|
|
2015
Q1 | – | Sell |
-42,282
| Closed | -$960K | – | 2310 |
|
|
2014
Q4 | $960K | Hold |
42,282
| – | – | ﹤0.01% | 2196 |
|
|
2014
Q3 | $821K | Sell |
42,282
-42,281
| -50% | -$821K | ﹤0.01% | 2220 |
|
|
2014
Q2 | $3.07M | Buy |
84,563
+15,781
| +23% | +$573K | ﹤0.01% | 2127 |
|
|
2014
Q1 | $2.67M | Hold |
68,782
| – | – | ﹤0.01% | 2006 |
|
|
2013
Q4 | $1.96M | Hold |
68,782
| – | – | ﹤0.01% | 2031 |
|
|
2013
Q3 | $2.46M | Hold |
68,782
| – | – | ﹤0.01% | 2034 |
|
|
2013
Q2 | $2.3M | Buy |
+68,782
| New | +$2.3M | ﹤0.01% | 2042 |
|